IL7R and leukemia: These results indicate that Kras mutation cooperates with IL7R mutation in upregulating IL-7R-mediated signaling and accelerating leukemic transformation, suggesting that one of the possible mechanisms by which additional lesions cooperate with IL7R mutation in driving leukemia is the upregulation IL-7R-mediated signaling.